Exposure to direct-to-consumer advertising is associated with overestimation of benefits regarding ultrahypofractionated radiation therapy for prostate cancer.
Joseph M CaputoHenry J LeeBennett ChilesElias S HyamsPublished in: Prostate cancer and prostatic diseases (2020)
DTC medical advertisements can be misleading and impact laypersons' impressions. In this case, viewing an advertisement created inaccurate impressions regarding effectiveness and safety of UHF for prostate cancer.